Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

A global view of comparability concepts.

J Petricciani¹

¹CancerVax, Carlsbad, CA 92008, USA.

Developments in Biologicals

|November 19, 2002

Summary

Evaluating manufacturing changes in biological products requires assessing safety and efficacy. Advances allow for specific regulatory guidance, but a harmonized approach is needed due to complex factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.

Biologicals : journal of the International Association of Biological Standardization·2009

Same author

WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11-12 June 2007.

Biologicals : journal of the International Association of Biological Standardization·2008

Same author

Cell substrates: where do we stand after 50 years of discussion?

Developments in biologicals·2006

Same author

Are cancer vaccines really the same as infectious disease vaccines?

Developments in biologicals·2004

Same author

An overview of cell DNA issues.

Developments in biologicals·2002

Same author

The next steps in HIV vaccine development.

AIDS research and human retroviruses·1992

Area of Science:

Biotechnology
Regulatory Science
Pharmaceutical Manufacturing

Background:

The concept of biological product comparability has evolved significantly over the last decade.
This evolution is driven by the need to assess manufacturing process changes and their impact on product attributes.

Purpose of the Study:

To discuss the evolving concept of biological product comparability.
To highlight the advancements in regulatory guidance from agencies in the U.S.A. and Europe.
To emphasize the need for a harmonized approach to evaluating manufacturing changes.

Main Methods:

Discussion of the broad spectrum of potential manufacturing process changes.
Analysis of complex factors involved in evaluating the significance of these changes.
Review of current regulatory landscapes in the U.S.A. and Europe.

Main Results:

Advances in technology enable more precise evaluation of biological product comparability.
Regulatory agencies have developed specific guidance for assessing manufacturing changes.
The evaluation of manufacturing changes involves complex, multifaceted considerations.

Conclusions:

The assessment of biological product comparability is crucial for ensuring safety and efficacy post-manufacturing changes.
Harmonization of approaches is essential for consistent and reliable evaluation across different regulatory jurisdictions.
Continued scientific and technological advancements will further refine the comparability assessment process.

Related Experiment Videos